PATENT CLAIM ANALYSIS

Application Number: 16233890
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "100000"]

Abstract:
The present invention relates to a glucagon derivative, a conjugate thereof, and a composition comprising the same, and a therapeutic use thereof, and in particular, for metabolic syndrome, hypoglycemia, and congenital hyperinsulinism.

Claim (Index 74):
The isolated conjugate of  claim 68 , wherein the linker is respectively linked to the peptide moiety and the biocompatible material moiety through covalent bonds, which are respectively formed by reacting one end of the linker with an amine group or thiol group of the biocompatible material moiety and reacting the other end of the linker with an amine group or thiol group of the peptide moiety.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 98.0
- Lexical Diversity: 1.48148
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15740668', '13810999', '16024014', '15313501', '15086499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8214422853110894
- 35 USC 102 Novelty (BERT): 0.6261191246106489
- Combined Prediction Score: 0.8019099692410454
- Mean Citation Score: 452.842674
- Max Citation Score: 747.8688
- Similarity Product: 503.3305745315552

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test